Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
NCT ID:
NCT02013427
Population Description:
25 patients received no treatment. Of the 57 treated individuals, 52 were allocated to placebo treatment (PTx) and 5 were allocated to active treatment (MTX, Naproxen + Esomeprazole) in a double-blind fashion.
Note: the MTx group was included for blinding purposes (i.e., so that we could tell patients they may receive a placebo or active treatment) hence why the large imbalance between groups. Participants were not informed about the odds for receiving active versus placebo treatment.
Study:
NCT02013427
Study Brief:
Results Section:
NCT02013427